CRISPR-CasΦ from huge phages is a hypercompact genome editor.
Patrick PauschBasem Al-ShayebEzra Bisom-RappConnor A TsuchidaZheng LiBrady F CressGavin J KnottSteven E JacobsenJillian F BanfieldJennifer A DoudnaPublished in: Science (New York, N.Y.) (2020)
CRISPR-Cas systems are found widely in prokaryotes, where they provide adaptive immunity against virus infection and plasmid transformation. We describe a minimal functional CRISPR-Cas system, comprising a single ~70-kilodalton protein, CasΦ, and a CRISPR array, encoded exclusively in the genomes of huge bacteriophages. CasΦ uses a single active site for both CRISPR RNA (crRNA) processing and crRNA-guided DNA cutting to target foreign nucleic acids. This hypercompact system is active in vitro and in human and plant cells with expanded target recognition capabilities relative to other CRISPR-Cas proteins. Useful for genome editing and DNA detection but with a molecular weight half that of Cas9 and Cas12a genome-editing enzymes, CasΦ offers advantages for cellular delivery that expand the genome editing toolbox.
Keyphrases
- genome editing
- crispr cas
- circulating tumor
- endothelial cells
- cell free
- single molecule
- induced apoptosis
- escherichia coli
- high resolution
- high throughput
- small molecule
- cell proliferation
- genome wide
- cell death
- mass spectrometry
- signaling pathway
- endoplasmic reticulum stress
- amino acid
- quantum dots
- binding protein
- high density